We and others previously demonstrated GDF8 and ActA are the two major ligands which mediate the muscle minimization actions of the ActRIIA/B receptors in non-obese mice and NHPs 22,28,30 , and we have further shown that dual blockade of GDF8 and ActA led to much larger increases in muscle mass than blocking either ligand individually, and that dual blockade matched the muscle growth actions of broader ActRIIA/B blockade 28 , similar to effects seen when using a dominant-negative type II receptor or pro-domains of GDF8 and activins 22,26,27
Gluzman-Poltorak Z, Cohen T, Herzog Y, Neufeld G
In addition, in cases where premiums or contributions for both family and single coverage were missing, the hotdeck procedure was revised to draw all four responses from a single firm
Other published rodent studies have used doses spanning from roughly 10 g/kg down to the nanogram-per-kilogram range, depending on the injury model and outcome measured
The manufacturer needs to demonstrate product quality together with their production capacity and delivery schedule and ability to provide custom solutions and WHO-GMP and ISO and FSSAI certifications
